With 0.58 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.38 million shares. The 52-week range on OVID shows that it touched its highest point at $3.79 and its lowest point at $0.56 during that stretch. It currently has a 1-year price target of $3.47. Beta for the stock currently stands at 0.28.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OVID was down-trending over the past week, with a drop of -9.52%, but this was down by -22.80% over a month. Three-month performance dropped to -45.51% while six-month performance fell -53.17%. The stock lost -84.60% in the past year, while it has lost -39.31% so far this year. A look at the trailing 12-month EPS for OVID yields -0.46 with Next year EPS estimates of -0.66. For the next quarter, that number is -0.17. This implies an EPS growth rate of 37.16% for this year and -42.22% for next year. EPS is expected to grow by 17.77% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 18.87%.
Float and Shares Shorts:
At present, 71.01 million OVID shares are outstanding with a float of 56.87 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OVID since 5 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.45341 being high and -$0.47667 being low. For OVID, this leads to a yearly average estimate of -$0.46504. Based on analyst estimates, the high estimate for the next quarter is -$0.13 and the low estimate is -$0.16. The average estimate for the next quarter is thus -$0.14.
